/BIOG.L
BIOG.L Stock - The Biotech Growth Trust PLC
Financial Services|Asset ManagementLSE
$1230.00+2.93%
+$35.00 (+2.93%) • Dec 22
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.90
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.93
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1353.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BIOG.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1217.70 – $1242.30
TARGET (TP)$1414.50
STOP LOSS$1131.60
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.67
52W High$1384.18
52W Low$612.70
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $-77,484,000 | $80.35M | $-37,654,000 | $-209,711,000 | $204.35M |
| Gross Profit | $-78,809,000 | $78.00M | $-42,967,000 | $-214,513,000 | $222.11M |
| Gross Margin | 101.7% | 97.1% | 114.1% | 102.3% | 108.7% |
| Operating Income | $-82,516,000 | $76.50M | $-36,691,000 | $-199,755,000 | $197.34M |
| Net Income | $-82,661,000 | $74.60M | $-41,298,000 | $-202,419,000 | $200.43M |
| Net Margin | 106.7% | 92.8% | 109.7% | 96.5% | 98.1% |
| EPS | $-2.62 | $2.07 | $-1.03 | $-4.88 | $5.01 |
Company Overview
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BIOG.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$2.73
Q4 2025
EPS Surprise History
Q1 22
No data
Q3 22
No data
Q2 23
No data
Q4 23
No data
Q2 24
No data
Q4 24
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 25, 2025 | — | $2.73 | — | — |
Q2 2025 | Jun 4, 2025 | — | $-2.87 | — | — |
Q4 2024 | Nov 20, 2024 | — | $0.25 | — | — |
Q2 2024 | Jun 5, 2024 | — | $2.44 | — | — |
Q4 2023 | Nov 9, 2023 | — | $1.00 | — | — |
Q2 2023 | Jun 15, 2023 | — | $-0.98 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.45 | — | — |
Q1 2022 | Mar 31, 2022 | — | $1.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $1.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.27 | — | — |
Q3 2020 | Sep 30, 2020 | — | $2.26 | — | — |
Q1 2020 | Mar 31, 2020 | — | $0.93 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.47 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-1.14 | — | — |
Q3 2018 | Sep 30, 2018 | — | $1.47 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-1.40 | — | — |
Q3 2017 | Sep 30, 2017 | — | $0.87 | — | — |
Q1 2017 | Mar 31, 2017 | — | $0.43 | — | — |
Q3 2016 | Sep 30, 2016 | — | $1.27 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.51 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BIOG.L
What is BIOG.L's current stock price?
The Biotech Growth Trust PLC (BIOG.L) is currently trading at $1230.00 per share. The stock has moved +2.93% today.
What is the analyst price target for BIOG.L?
No analyst price targets are currently available for this stock.
What sector is The Biotech Growth Trust PLC in?
The Biotech Growth Trust PLC operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the LSE exchange.
What is BIOG.L's market cap?
The Biotech Growth Trust PLC has a market capitalization of $0.26 billion, making it a small-cap company.
Does BIOG.L pay dividends?
No, The Biotech Growth Trust PLC does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAAEV.L
Albion Enterprise VCT PLC
$105.00
Mkt Cap: $25.0B
AATG.L
Albion Technology & General VCT PLC
$66.00
Mkt Cap: $25.0B
AJOT.L
AVI Japan Opportunity Trust PLC
$168.00
Mkt Cap: $22.8B
BGUK.L
Baillie Gifford UK Growth Trust plc
$206.00
Mkt Cap: $24.0B
CMPG.L
CT Global Managed Portfolio Growth Ord
$305.00
Mkt Cap: $27.4B
DIVI.L
The Diverse Income Trust plc
$105.00
Mkt Cap: $24.8B
IBT.L
International Biotechnology Trust plc
$990.00
Mkt Cap: $31.6B
MTE.L
Montanaro European Smaller Companies Trust plc
$164.00
Mkt Cap: $22.3B
MWY.L
Mid Wynd International Investment Trust plc
$772.00
Mkt Cap: $25.7B
PEMB.L
Pembroke VCT plc
$90.50
Mkt Cap: $24.2B
Explore stocks similar to BIOG.L for comparison